Advertisement
Research Article| Volume 4, ISSUE 4, P745-761, December 1984

Laboratory Evaluation of Hyper- and Hypoglycemic States

      This paper is only available as a PDF. To read, Please Download here.
      Appropriate use of test strategies requires not only an appreciation of analytic considerations and the ability of the tests to confirm or exclude the hypotheses, but also an understanding of the underlying pathophysiology and clinical features of the problems to be addressed. This discussion covers disease definition, pathophysiology, analytic considerations, and strategies for diagnosis and management.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Al Sayegh H.
        • Jarret R.J.
        Oral glucose tolerance tests and the diagnosis of diabetes: Results of a prospective study based on the Whitehall survey.
        Lancet. 1979; 2: 432-433
        • Alviggi L.
        • Hoskins P.J.
        • Pyke D.A.
        • et al.
        Pathogenesis of insulin-dependent diabetes: A role for activated T-lymphocytes.
        Lancet. 1984; 2: 4-5
        • Bennet P.H.
        The diagnosis of diabetes: New international classification and diagnostic criteria.
        Ann. Rev. Med. 1983; 34: 295-309
        • Birmingham Diabetes Survey Working Group
        Five year follow-up report on the Birmingham Diabetes Survey of 1962.
        Br. Med. J. 1970; 3: 301-305
        • Birmingham Diabetes Survey Working Group
        Ten year follow-up report on Birmingham diabetes survey of 1961.
        Br. Med. J. 1976; 2: 35-37
        • Burke M.D.
        Assessing the clinical utility of laboratory methods.
        Clin. Lab. Med. 1981; 1: 21-37
        • Burke M.D.
        Diabetes mellitus: Test strategies for diagnosis and management.
        Postgrad. Med. 1979; 66: 213-219
        • Burke M.D.
        Hypoglycemia: Strategies for laboratory investigation.
        Postgrad. Med. 1979; 66: 131-138
        • Cahill G.F.
        Hypoglycemia.
        in: Rubenstein E. Federman D.D. Scientific American Medicine. Scientific American Inc., New York1983
        • Chalen S.A.
        • McLaughlin J.V.
        • Mersey J.H.
        • et al.
        The use of the plasma epinephrine response in the diagnosis of idiopathic postprandial syndrome.
        J.A. M.A. 1984; 251: 612-615
        • Editorial
        Glycosylation and disease.
        Lancet. 1984; 2: 19-20
      1. Expert Committee on Diabetes Mellitus, World Health Organization, WHO Technical Report Series No. 310:12, 1965.

        • Fairbanks V.F.
        • Zimmerman B.R.
        Measurement of glycosylated hemoglobin by affinity chromatography.
        Mayo Clin. Proc. 1983; 58: 770-773
        • Fajans S.S.
        • Conn J.W.
        The early recognition of diabetes mellitus.
        Ann. N.Y. Acad. Sei. 1959; 82: 208
        • Fajans S.S.
        • Floyd Jr., J.C.
        Fasting hypoglycemia in adults.
        N. Engl. J. Med. 1972; 294: 766-772
        • Fajans S.S.
        • Cloutier M.C.
        • Crowther R.L.
        Clinical and etiological heterogeneity of idiopathic diabetes mellitus.
        Diabetes. 1978; 27: 1112-1125
        • Felig P.
        • Cherif A.
        • Minagawa A.
        • et al.
        Hypoglycemia during prolonged exercise in normal men.
        N. Engl. J. Med. 1982; 306: 895-900
        • Fitzgerald M.G.
        • Keen H.
        Diagnostic classification of diabetes.
        Br. Med. J. 1964; 1: 1568
        • Gerich J.
        • Cryer P.
        • Rizza R.
        Hormonal mechanisms of acute glucose counter regulation: The relative roles of glucagon, epinephrine, norephrine, growth hormone and cortisol.
        Metabolism. 1980; 29: 1164-1175
        • Gerich J.E.
        Role of growth hormone in diabetes mellitus.
        N. Engl. J. Med. 1984; 310: 848-849
        • Goldstein D.E.
        Is glycosylated hemoglobin clinically useful?.
        N. Engl. J. Med. 1984; 310: 384-385
        • Hoekstra J.B.L.
        • Van Rijh H.J.M.
        • Thijssen J.H.H.
        • et al.
        C-peptide reactivity as a measure of insulin dependency in obese diabetic patients treated with insulin.
        Diabetes Care. 1982; 5: 585-591
        • Horwitz D.L.
        • Juzuya H.
        • Rubenstein A.H.
        Circulating serum C-peptide: A brief review of diagnostic implications.
        N. Engl. J. Med. 1976; 295: 207-209
        • Howanowitz P.J.
        • Howanowitz J.H.
        Carbohydrates.
        in: Henry J.B. Clinical Diagnosis and Management by Laboratory Methods. 17th ed. W. B. Saunders Co., Philadelphia1984: 168
        • Jarret R.J.
        • Keen H.
        • Fuller J.H.
        • et al.
        Worsening to diabetes in men with impaired glucose tolerance (borderline diabetes).
        Diabetologia. 1979; 16: 25-30
        • Johnson D.D.
        • Dorr K.E.
        • Swenson W.M.
        • et al.
        Reactive Hypoglycemia.
        J.A.M.A. 1980; 243: 1151-1155
        • Kolterman O.G.
        • Scarlett T.A.
        • Olefsky J.M.
        Insulin resistance in non-insulin dependent, Type II diabetes mellitus.
        Clin. Endocrinol. Metab. 1982; 11: 363-388
        • Marks V.
        Hypoglycemia: 2 Other Causes.
        Clin. Endocrinol. Metab. 1976; 5: 769-782
        • Massar V.
        • Eschwege E.
        • Valleron A.J.
        Imprecision of new criteria for the oral glucose tolerance test.
        Diabetologia. 1983; 24: 100-106
        • Merimee T.J.
        • Tyson J.E.
        Stabilization of plasma glucose during fasting: Normal variations in two separate studies.
        N. Engl. J. Med. 1974; 291: 1275-1278
        • Merimee T.J.
        • Zapf J.
        • Froesch E.R.
        Insulin-like growth factors: Studies in diabetics with and without retinopathy.
        N. Engl. J. Med. 1983; 309: 527-530
        • Miller S.I.
        • Wallace R.J.
        • Musher D.M.
        • et al.
        Hypoglycemia as a manifestation of sepsis.
        Am. J. Med. 1980; 68: 649-654
        • Monnier V.M.
        • Cerami A.
        Non-enzymatic glycosylation and browing of proteins in diabetes.
        Clin. Endocrinol. Metab. 1982; 11: 431-452
      2. Nanji, A. A.: Hypoglycemia: When it’s the real thing. Diagnostic Medicine, October 1983, pp. 60–70.

        • Nathan D.M.
        • Singer D.E.
        • Hurxthal K.
        • et al.
        The clinical information value of the glycosylated hemoglobin assay.
        N. Engl. J. Med. 1984; 310: 341-346
        • National Diabetes Data Group
        Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance.
        Diabetes. 1979; 28: 1039-1057
        • O’Sullivan J.M.
        • Mahan C.M.
        Criteria for the oral glucose tolerance test in pregnancy.
        Diabetes. 1964; 13: 278
        • O’Sullivan J.B.
        • Mahan C.M.
        Prospective study of 352 young patients with chemical diabetes.
        N. Engl. J. Med. 1968; 278: 1038
        • Passey R.B.
        Evaluation and comparison of ten glucose methods and the reference method recommended in the proposed class standard (1974).
        Clin. Chem. 1977; 23: 131-139
        • Peacock I.
        • Tattersall R.
        Methods of monitoring diabetic control.
        Clin. Endocrinol. Metab. 1982; 11: 485-501
        • Pettit D.J.
        • Knowler W.C.
        • Lisse J.
        • et al.
        Development of retinopathy and proteinuria in relation to plasma glucose concentrations in Pima Indians.
        Lancet. 1980; 2: 1050-1052
        • Position Paper
        Health and Public Policy Committee, American College of Physicians.
        Ann. Intern. Med. 1983; 99: 272-274
        • Press M.
        • Tamborlane W.V.
        • Sherwin R.S.
        The importance of raised growth hormone levels in mediating the metabolic derangements of diabetes.
        N. Engl. J. Med. 1984; 310: 810-815
        • Raskin P.
        Diabetic regulation and its relationship to microangiopathy.
        Metabolism. 1978; 27: 235-252
        • Remein G.R.
        • Wilkerson H.L.C.
        The efficiency of screening tests for diabetes.
        J. Chronic Dis. 1961; 13: 6
        • Rendell M.
        The expanding clinical use of C-peptide radioimmunoassay.
        Acta Diabēt. Lat. 1983; 20: 105-113
        • Rendell M.
        C-peptide levels as a criterion in treatment of maturity-onset diabetes.
        J. Clin. Endocrinol. Metab. 1983; 57: 1198-1206
        • Robbins D.C.
        • Tager H.S.
        • Rubenstein A.H.
        Biologic and clinical importance of proinsulin.
        N. Engl. J. Med. 1984; 310: 1165-1175
        • Senior G.
        Neonatal hypoglycemia.
        N. Engl. J. Med. 1973; 289: 790-793
        • Service F.J.
        Insulinoma: Clinical and diagnostic features of 60 consecutive cases.
        Mayo Clin. Proc. 1976; 51: 417-429
        • Service F.J.
        Hypoglycemia.
        N.Y. State J. Med. 1978; 78: 2122-2123
        • Sharp C.L.
        • Butterfield W.J.H.
        • Keen H.
        Diabetes survey in Bedford.
        Proc. R. Soc. Med. 1962; 57: 193
        • Skyler J.S.
        • Skyler D.L.
        • Deigler D.E.
        • et al.
        Algorithms for adjustment of insulin dosage by patients who monitor glucose.
        Diabetes Care. 1981; 4: 311-318
        • Siperstein M.D.
        The glucose tolerance test: A pitfall in the diagnosis of diabetes mellitus.
        Adv. Intern. Med. 1975; 20: 297-323
        • Siperstein M.D.
        Diabetic microantiopathy and the control of blood glucose.
        N. Engl. J. Med. 1983; 309: 1577-1579
        • Taylor S.I.
        • Grunberger G.
        • Marcus-Samuels B.
        • et al.
        Hypoglycemia associated with antibodies to the insulin receptor.
        N. Engl. J. Med. 1982; 307: 1422-1426
        • Tchobroutsky G.
        Relation of diabetic control to development of microvascular complications.
        Diabetologia. 1978; 15: 143-152
        • Unger R.H.
        • Orci L.
        Glucagon and the A-cell.
        N. Engl. J. Med. 1981; 304 (1575–1580): 1518-1524
        • Unger R.H.
        Meticulous control of diabetes: Benefits, risks and precautions.
        Diabetes. 1982; 31: 479-483
        • West K.M.
        Substantial differences in the diagnostic criteria used by diabetes experts.
        Diabetes. 1975; 24: 641-644
        • White N.H.
        • Skor D.A.
        • Cryer P.E.
        • et al.
        Identification of Type I diabetic patients at increased risk for hypoglycemia during intensive therapy.
        N. Engl. J. Med. 1983; 305: 485-491
        • White N.T.
        • Warrell D.A.
        • Chanthavanich P.
        • et al.
        Severe hypoglycemia and hyperinsulinemia in falciparum malaria.
        N. Engl. J. Med. 1983; 309: 61-66
      3. World Health Organization Expert Committee on Diabetes Mellitus, Second Report. WHO Technical Report Series 646, Geneva, WHO, 1980.

        • Yager J.
        • Young R.T.
        Non-hypoglycemia is an epidemic condition.
        N. Engl. J. Med. 1974; 21: 907-908